Breast imaging technology: Imaging biochemistry - applications to breast cancer
AUTOR(ES)
Ronen, Sabrina M
FONTE
BioMed Central
RESUMO
The use of magnetic resonance spectroscopy (MRS) to investigate breast tumour biochemistry in vivo is reviewed. To this end, results obtained both from patients in vivo and from tumour extracts and model systems are discussed. An association has been observed between transformation and an increase in phosphomonoesters (PMEs) detected in the 31P MRS spectrum, as well as an increase in choline-containing metabolites detected in the 1H spectrum. A decrease in PME content after treatment is associated with response to treatment as assessed by tumour volume. Experiments in model systems aimed at understanding the underlying biochemical processes are presented, as well as data indicating the usefulness of MRS in monitoring the uptake and metabolism of some chemotherapeutic agents.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=150033Documentos Relacionados
- Breast imaging technology: Probing physiology and molecular function using optical imaging - applications to breast cancer
- Breast imaging technology: Recent advances in imaging endogenous or transferred gene expression utilizing radionuclide technologies in living subjects - applications to breast cancer
- Breast imaging technology: Application of magnetic resonance imaging to angiogenesis in breast cancer
- Breast imaging technology: Current and future technologies for breast cancer imaging
- Breast imaging technology: Application of magnetic resonance imaging to early detection of breast cancer
